
Overview
Master Pharm is a contract manufacturer of dietary supplements, cosmetics, and medical products. The company offers comprehensive project implementation services for dietary supplements, from concept to product, and develops product documentation at every stage of product rollout. They assist clients with product notifications to relevant authorities.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $496,756 |
Filing timeliness
5 of 6 financial statements were filed late (the longest delay 91 days for 2023). All were audited by a statutory auditor.
- 202520/07/2026
- 202404/09/2025
- 202314/10/2024
- 202206/08/2023
- 202118/07/2022
- 202015/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
- Dietary supplements
- Cosmetics
- Medical devices
- Probiotics
- Over-the-counter medicines
- Product formulations
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Tag Manager
Trademarks
The company holds 15 active trademarks registered with the Polish Patent Office. 5 marks have expired or were not registered. The first mark was filed in 2012.
| Mark | Protected until | |
|---|---|---|
| hepavetcomplex suplement diety | Sep 28, 2033 | |
| Witamina D3 2000 suplement diety | Sep 28, 2033 | |
| suplement diety witamina A+E avet | Sep 28, 2033 | |
| Morwa Biała suplement diety + | Sep 28, 2033 | |
| Sinavet suplement diety | Mar 25, 2032 |
Authorized Representatives
Manner of representation
The following are authorized to represent the company and make declarations of will on behalf of the company: 1. in the case of a one-person management board, the President of the Management Board independently; 2. in the case of a multi-member management board, the President of the Management Board independently, two members of the management board jointly, or one member of the management board jointly with a commercial proxy.
Supervisory board
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2002-11-21.
07 1240 2656 1787 0010 7033 9173
07 1240 5527 1978 0010 2676 7498
48 1240 2656 1978 0010 6849 5779
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $119.6K$119,583 |
Buildings and premises | $1.5M$1,497,870 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jun 23, 2026 | Call to creditors |
Public aid
9 public aid cases recorded, with a total value of $1,570,880.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Oct 4, 2021 | Regional investment aid | –– | Prezes Banku Gospodarstwa Krajowego | |
| May 8, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Polski Fundusz Rozwoju S.A. | |
| Dec 19, 2018 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Prezydent Miasta Łódź |
European Funds
5 projects co-financed from European Funds recorded, with total EU co-financing of $543,750.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-01-01 | Implementation of innovative vegan soft capsule technology | $169.9K$169,863 | Operational Programme Smart Growth | |
| 2018-10-01 | Development by Master Pharm S.A. of iron chelation technology to improve its bioavailability | $156.8K$156,812 | Regional Operational Programme of the Łódź Voivodeship for 2014–2020 | |
| 2018-10-01 | Development of magnesium chelation technology by Master Pharm S.A. | $144K$144,013 | Regional Operational Programme of the Łódź Voivodeship for 2014–2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Prosuplement Group sp. z o.o. | $34,819,545.29 | prosuplement.com | ||
| Zakłady Farmaceutyczne Colfarm S.A. | $27,692,749.78 | colfarm.pl | ||
| Exim Pharma sp. z o.o. | $24,694,130.27 | eximpharma.eu | ||
| Global Pharma Cm S.A. | $24,132,016.98 | globalpharma.pl | ||
| Starpharma sp. z o.o. | $22,849,701.01 | starpharma.pl | ||
| Europharma Alliance sp. z o.o. | $15,439,864.68 | pharmaalliance.eu | ||
| Puwer Polska sp. z o.o. | $6,855,625.12 | puwer.pl | ||
| Nutramatic sp. z o.o. | $6,205,312.16 | nutramatic.pl | ||
| Stella Nutrition sp. z o.o. | $5,376,276.72 | stellagroup.pl | ||
| H+B Group sp. z o.o. | $3,806,379.96 | hbgroup.global |
Change history
| Date | Event | |
|---|---|---|
| 2016-05-18 | Share capital increase (185,000.00 PLN → 215,000.00 PLN) | |
| 2015-07-30 | Entered in the register |
FAQ
Last updated: 2026-08-20